MycoMed is pleased to announce that the United States Patent and Trademark Office has issued a Notice of Allowance for US Patent Application Pub. No. 20130017561. The allowed claims relate to methods for the detection of Aspergillus fumigatus.
In April 2018, MycoMed Technologies published a paper in Clinical Infectious Disease titled: “Urine Antigen Detection as an Aid to Diagnose Invasive Aspergillosis”. To read, please download the paper below. Urine Antigen Detection as an Aid to Diagnose Invasive Aspergillosis
On March 13, 2018 MycoMed Technologies was awarded US patent# 9,915,657 for a lateral flow device (LFD) for the detection of Aspergillus antigens in urine. Aspergillosis is a common infection in people with weakened immune systems, especially after transplantation or cancer therapy. This simple assay will allow for early detection to prevent severe disease. View [...]